Press launch MHRA approves GLP –1 receptor agonist semaglutide to cut back chance of great heart issues in obese or overweight Grownups Semaglutide is the initial weightloss drug accepted in the united kingdom as being a preventative treatment for those with founded cardiovascular diseaseWegovy® is actually a weight loss drug made up of the Ener